Please login to the form below

Not currently logged in
Email:
Password:

MHRA appoints Michael Rhodes as medical director of devices

He will take over from Dr Susanne Ludgate, who is retiring in December

MHRA medical director devices Michael RhodesThe UK's Medicines and Healthcare products Regulatory Agency (MHRA) has appointed Michael Rhodes to be its new medical director of devices.

He will take up the role on November 8 and replaces Dr Susanne Ludgate who is retiring in December after 15 years in the post and 21 years working for the Agency.

Rhodes has been a consultant surgeon since 1995, specialising in weight loss, hernia, gastrointestinal and laparoscopic surgery, and has sat on NICE's Interventional Procedures Advisory Committee for the last four years.

Professor Sir Kent Woods, chief executive of the MHRA, said: “I am delighted that Michael is joining the MHRA. His clinical expertise and experience will be vital in our role of safeguarding public health and ensuring medical devices are fit for purpose.

“Dr Susanne Ludgate has been a huge asset to the MHRA during her time here and she has been a continued source of good clinical advice to health professionals and the public. She is well-known and respected throughout the healthcare profession and industry.”

Dr Ludgate joined the Medical Devices Agency in 1991, before it merged with its medicines counterpart in 2003 to form the MHRA. She served as senior medical officer until 1997, when she was appointed she was appointed clinical director.

12th October 2012

From: Research, Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics